Johnson & Johnson JNJ announces its next round of earnings Tuesday. Here is Benzinga's everything-that-matters guide for the Q3 earnings announcement.
Earnings and Revenue
Based on management's projections, Johnson & Johnson analysts model for earnings of $2.03 per share on sales of $20.03 billion.
In the same quarter last year, Johnson & Johnson announced EPS of $1.90 on revenue of $19.65 billion. The analyst consensus estimate would represent a 6.84 percent increase in the company's EPS figure. Revenue would be up 1.93 percent from the year-ago period. In comparison to analyst estimates in the past, here's how the company's reported EPS stacks up:
| Quarter | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
| EPS Estimate | 2.06 | 2 | 1.72 | 1.8 |
| EPS Actual | 2.1 | 2.06 | 1.74 | 1.9 |
Stock Performance
Over the past 52-week period, shares of Johnson & Johnson have declined 2.03 percent. Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The popular rating by analysts on Johnson & Johnson stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
Conference Call
Johnson & Johnson's Q3 conference call is scheduled to begin at 8:30 a.m. ET and can be accessed here: https://edge.media-server.com/m6/p/vpedz4eu
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
